v3 Template
I

Infinity Bio

Biotechnology / Immunology ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$8.0M
Funding Rounds
1
Last Funding
2025-06-18

About Infinity Bio

Infinity Bio is a company focused on antibody profiling services, translating the antibody 'reactome'—the set of all possible binding interactions between antibodies and antigens—into biological insights to transform immunology research. Their mission is to provide comprehensive, reliable, and fast antibody reactome profiling to support health and disease research.

Products & Services

VirSIGHT™: Human Viruses:Comprehensive peptide library covering all viruses known to infect humans.
HuSIGHT™: Human Proteins:Comprehensive coverage of all human protein sequences with a combination of peptides and full-length proteins.
Custom Antigen Libraries:Bespoke libraries covering any set of protein sequences across any kingdom of life.
mAb Characterization:Specialized service for monoclonal antibody characterization.
MIPSA Technology:Molecular Indexing of Proteins by Self-Assembly technology for decoding antibody reactome using advanced DNA synthesis and sequencing, with comprehensive antigen libraries, cutting-edge informatics, and industry-leading quality systems.
Bioinformatics & Reporting:Standard reporting and fee-for-service statistical analyses to maximize insights from antibody reactome studies.

Specialties

Antibody Profiling Antibody Reactome Analysis Molecular Indexing of Proteins by Self-Assembly (MIPSA) Infectious Diseases Research Autoimmune Disease Research Vaccine Development Allergy Research Cancer Immunotherapy Target and Biomarker Discovery Precision Medicine

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 8000000
MR: -
FA: $8M
FAN: 8000000 		D: 2025-06-18
FD: 2025-06-18 		4 investors
Series A Latest
2025-06-18
$8.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

H

H. Benjamin Larman

CSO / Founder

LinkedIn (Pro only)
J

Joy M. Nassif

CEO

LinkedIn (Pro only)
J

Jean-Philippe Laine

Vice President, BD & Sales

LinkedIn (Pro only)
J

Joel Credle

Director, R&D

M

Megan Coombs

Sr. Director, Operations & Service Excellence

K

Katy Shaw-Saliba

Director, Scientific Development

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

Infinity Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Immunology
Company Size
~420 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro